Dengue Tests: Understanding Your Blood Test Series

1. Overview: What these tests reveal and why they are important

Dengue is a mosquito-borne viral infection caused by four distinct serotypes (DENV-1 to DENV-4). It is endemic in tropical and subtropical regions, including the Indian subcontinent, Southeast Asia, and Latin America. The clinical presentation ranges from asymptomatic or mild febrile illness to severe dengue (dengue haemorrhagic fever/dengue shock syndrome), characterised by plasma leakage, bleeding, and organ impairment.

Laboratory diagnosis is essential because dengue mimics many other acute febrile illnesses – malaria, typhoid, leptospirosis, chikungunya, and Zika. Three main classes of tests are used:

· NS1 antigen: Detects a non‑structural viral protein produced early in infection (days 1–5). Positive result confirms acute dengue.

· Dengue IgM: Immunoglobulin M antibodies appear from day 3–5, peak at 2 weeks, and decline over 2–3 months. Positive IgM indicates current or recent infection.

· Dengue IgG: Immunoglobulin G antibodies rise from day 7–10 and persist for life. A four‑fold rise in paired sera confirms acute infection; a single high titre in a febrile patient suggests secondary infection (more likely to be severe).

· PCR (polymerase chain reaction): Detects viral RNA directly; reference standard for early diagnosis and serotyping. Not widely available in resource‑limited settings.

Interpretation requires combining these tests with the date of symptom onset and previous dengue exposure history.

---

2. What does it measure

a. Units of measurement

· NS1 antigen: Reported qualitatively as Positive or Negative. Some laboratories provide an index value (e.g., Panbio units); values above a manufacturer‑defined cut‑off (usually >1.0 or 1.2) are positive.

· Dengue IgM and IgG:

· Qualitative: Positive, Negative, Equivocal

· Semi‑quantitative: Titres (e.g., 1:40, 1:80) or index values (e.g., >1.1 positive, 0.9–1.1 equivocal)

· PCR: Detected / Not detected; or viral load in copies/mL or IU/mL (not routinely used for clinical decision‑making).

b. Normal range and interpretation

· Healthy, non‑infected individual: Negative for NS1, IgM, IgG, and PCR.

· Primary acute dengue (first infection):

· Days 1–5: NS1 positive; IgM negative/equivocal; IgG negative.

· Days 5–10: NS1 declining; IgM positive; IgG low or negative.

· Day 10: NS1 negative; IgM positive; IgG positive (rising).

· Secondary acute dengue (previous infection with different serotype):

· Rapid, high IgG response within days; IgM may be blunted or absent.

· NS1 often positive early but may be negative if prior immunity clears virus faster.

· IgG positive at high titre in acute phase; IgM negative or low.

· Past dengue (recovered): IgM negative (or low); IgG positive (persists for life).

---

3. Other factors connected to this

a. Direct correlation (factors that affect test positivity)

· Timing of sample collection – the single most important variable.

· NS1: highest sensitivity days 1–5; declines rapidly thereafter.

· IgM: detectable from day 3–5; peak at 10–14 days.

· IgG: detectable from day 7–10; continues to rise in convalescence.

· Secondary infection – IgM may be low or absent; IgG rises within 3–5 days to very high levels.

· Cross‑reactivity with other flaviviruses – Zika, yellow fever, Japanese encephalitis, West Nile. This is a major limitation in regions where multiple flaviviruses co‑circulate. Vaccination against yellow fever or Japanese encephalitis can also cause false‑positive dengue serology.

· Vaccination history – Dengvaxia (CYD‑TDV) recipients may have dengue antibodies without natural infection; serological diagnosis is unreliable in vaccinated individuals.

· Immunocompromised states – HIV, malnutrition, immunosuppressive therapy: antibody responses may be delayed or absent; PCR is preferred.

· Rheumatoid factor – can cause false‑positive IgM.

b. Indirect correlation (factors influencing interpretation)

· Age – infants may have maternal IgG; serology difficult to interpret.

· Prior dengue exposure – determines primary vs. secondary pattern; crucial for risk stratification.

· Severity of illness – secondary infection and certain viral genotypes are associated with higher risk of severe dengue.

· Co‑infections – dengue with malaria, typhoid, or leptospirosis occurs; serological cross‑reactivity can mislead.

· Laboratory method – rapid immunochromatographic tests (ICT) have lower sensitivity/specificity than ELISA; false positives and negatives are more common with rapid cards.

---

4. Disorders related to abnormal values

a. When positive (or specific patterns)

· NS1 positive + IgM negative + IgG negative = Acute primary dengue (early, first 3–5 days). Highly specific.

· NS1 positive + IgM positive + IgG negative/low = Acute primary dengue (days 5–7).

· NS1 positive + IgM negative + IgG positive (high) = Acute secondary dengue (early phase).

· NS1 negative + IgM positive + IgG positive (high) = Acute secondary dengue (later phase) or recent primary dengue (if IgG not high).

· NS1 negative + IgM positive + IgG negative = Acute primary dengue (after day 7) or recent infection (up to 3 months).

· NS1 negative + IgM negative + IgG positive = Past dengue infection (not current illness).

· PCR positive = Definitive acute dengue; can be positive when NS1 is already negative.

Clinical correlation:

· Dengue fever (DF) – febrile illness with two or more of: headache, retro‑orbital pain, myalgia, arthralgia, rash, leucopenia, mild haemorrhagic manifestations.

· Dengue haemorrhagic fever (DHF) – DF criteria plus plasma leakage (haemoconcentration, ascites, pleural effusion, hypoalbuminaemia) and thrombocytopenia (≤100,000/µL).

· Dengue shock syndrome (DSS) – DHF with circulatory failure, narrow pulse pressure, hypotension.

· Expanded dengue syndrome – atypical manifestations (hepatic, renal, neurological, cardiac).

b. When negative (but clinical suspicion remains high)

· Sample drawn too early – NS1 may be negative in first 24 hours; repeat at 48–72 hours if fever persists.

· Sample drawn too late – NS1 negative after day 5; rely on IgM.

· Secondary infection – IgM may be undetectable; IgG rises rapidly; paired acute and convalescent sera required.

· Immunocompromised – poor antibody production; PCR is essential.

· Infection with a different serotype or flavivirus – false negative dengue tests; consider Zika, chikungunya, etc.

· Poor quality rapid test – false negatives occur; ELISA is more reliable.

---

5. Best way to address aberrant levels

Critical principle: No specific antiviral therapy exists for dengue. Management is entirely supportive, focused on symptom relief, careful fluid balance, and prevention/management of complications. Positive dengue tests guide clinical suspicion and public health notification; they do not change the fact that treatment is supportive. Do not treat the test result; treat the patient.

a. Quick ways or using Medications (Medical Management)

No specific antiviral is approved. The following interventions are guideline‑based supportive care:

· Fever and pain:

· Paracetamol (acetaminophen) – 10–15 mg/kg every 6 hours (max 4 g/day). Do not exceed; risk of hepatotoxicity.

· AVOID NSAIDs (ibuprofen, aspirin, diclofenac, naproxen) – increased risk of gastritis, bleeding, and Reye syndrome.

· Fluid management (critical phase):

· Oral rehydration – oral rehydration salts (ORS), coconut water, clear soups, fruit juices (without added sugar).

· Intravenous fluids – indicated only if unable to tolerate oral intake, or in compensated/decompensated shock. Isotonic crystalloids (Ringer’s lactate, normal saline) are used; careful monitoring to avoid fluid overload.

· Platelet transfusion:

· NOT routinely indicated. Prophylactic transfusion does not prevent bleeding and may cause volume overload or transfusion reactions.

· Consider transfusion only if: active bleeding, or platelet count <10,000–20,000/µL with high risk of bleeding. Evidence base is weak; thresholds vary by local protocols.

· Blood transfusion: For significant haemorrhage; packed red cells.

· Corticosteroids: Not recommended; trials have shown no benefit.

· Hospitalisation criteria: Warning signs (abdominal pain, persistent vomiting, fluid accumulation, mucosal bleed, lethargy, hepatomegaly, rising haematocrit with falling platelets), comorbidities, pregnancy, infancy, elderly, social circumstances.

All medical decisions must be made by a qualified physician. Dengue can deteriorate rapidly; do not manage at home if warning signs appear.

b. Using Supplements or Holistic medicine (Adjunctive, supportive only)

No supplement cures dengue. Some traditional remedies have been studied for supportive effects – particularly on platelet recovery. These are adjuncts, not substitutes, for proper medical monitoring. Use only under medical supervision.

· Papaya leaf extract (Carica papaya) –

· Most widely studied traditional remedy for dengue. Several small randomised trials suggest it may shorten time to platelet recovery and reduce hospital stay.

· Mechanism: Thought to stabilise platelet membranes, reduce oxidative stress, and upregulate thrombopoietin.

· Dose: Standardised extract 500–1000 mg twice daily; or fresh leaf juice (20–30 mL) once or twice daily.

· Form: Choose extracts standardised to carpaine content. Avoid adulterated products.

· Caution: Can cause nausea; very high doses may be hepatotoxic. Not for self‑medication without physician awareness.

· Giloy / Guduchi (Tinospora cordifolia) –

· Widely used in Ayurveda for fevers and immunomodulation.

· Evidence: Small studies suggest antipyretic, anti‑inflammatory, and possible platelet‑enhancing effects. Evidence level low.

· Form: Standardised aqueous extract; decoction of stem; caution in autoimmune conditions.

· Note: Often combined with other herbs; avoid synthetic folic acid/cyanocobalamin‑containing blends.

· Vitamin D3 –

· Deficiency associated with more severe dengue. Supplementation may support immune regulation.

· Source: Lichen‑derived cholecalciferol (D3), not D2.

· Dose: 1000–2000 IU daily; higher if documented deficiency.

· Zinc –

· Reduces duration of acute febrile illness in children. May support immune function.

· Form: Zinc picolinate, zinc acetate, or zinc citrate. Avoid zinc oxide.

· Dose: 20–40 mg elemental zinc daily during acute illness.

· Vitamin C –

· Antioxidant; may reduce oxidative stress. No high‑quality evidence for dengue specifically.

· Form: Liposomal vitamin C (enhanced absorption) or whole food sources.

· Dose: 500–1000 mg daily.

· Probiotics –

· Support gut health during and after febrile illness; may reduce antibiotic‑associated diarrhoea if antibiotics were inadvertently given.

· Source: Non‑dairy, plant‑based fermentation cultures (Lactobacillus rhamnosus GG, Saccharomyces boulardii, Bifidobacterium lactis).

· Avoid products with synthetic folic acid or cyanocobalamin fillers.

· Herbs and Phytochemicals from Indian subcontinent –

· Tulsi (Ocimum sanctum): Antipyretic, anti‑inflammatory, immunomodulatory. Traditionally used in fevers. Tea or standardised extract.

· Amla (Emblica officinalis): Richest natural vitamin C source; antioxidant, hepatoprotective. Fresh fruit, juice, or extract.

· Neem (Azadirachta indica): Antiviral properties in vitro; traditional use in fevers. Caution: hepatotoxic in high doses; not recommended in acute dengue without expert guidance.

· Ginger (Zingiber officinale): Antiemetic; useful for nausea. Tea or fresh juice.

· Curcumin (turmeric): Anti‑inflammatory; poorly absorbed without bioavailability enhancers. Use phytosome formulation with piperine if used. Evidence for dengue specifically is absent.

Critical caution: Many proprietary “dengue kits” or “fever mixtures” contain undeclared steroids, synthetic folic acid, cyanocobalamin, or paracetamol (leading to inadvertent overdose). Use only single‑ingredient, independently tested extracts. Always inform your physician about any herbal remedies.

c. Using Diet and Foods (During Illness and Convalescence)

Acute dengue causes anorexia, nausea, and mucosal inflammation. The critical phase (around defervescence, days 4–6) carries the highest risk of plasma leakage and shock. Diet must be easily digestible, non‑irritating, and supportive of hydration and platelet recovery. Ecological hierarchy applies during convalescence and long‑term; acute phase prioritises digestibility and safety.

Phase 1: Acute febrile illness (days 1–5)

· Hydration is paramount:

· Oral rehydration salts (ORS) solution – standard composition, small frequent sips.

· Coconut water – rich in potassium, electrolytes, easily tolerated.

· Rice gruel (congee, kanji) – provides fluid, calories, easily digested.

· Clear vegetable soups (pumpkin, carrot, bottle gourd) – without spices, cream, or oil.

· Foods to offer:

· Ripe, mashed banana – potassium, energy; easily tolerated.

· Stewed apple (without skin) – pectin, easy digestion.

· Buttermilk (low‑fat, unsalted, no spices) – if dairy tolerated; provides probiotics, hydration.

· Ragi (finger millet) porridge – nutrient‑dense, easily digested.

· Khichdi (rice + moong dal, cooked very soft, minimal ghee, no spices) – ideal during transition from liquid to semi‑solid.

· Foods to avoid:

· All raw vegetables and salads – infection risk, difficult to digest.

· High‑fibre whole grains, nuts, seeds – mechanical irritation of inflamed gut.

· Spicy, oily, fried foods – worsen gastritis.

· Red meat, poultry, fish – not required, hard to digest, ecologically detrimental.

· Dark coloured beverages (tea, coffee) – may interfere with hydration; limit.

Phase 2: Critical phase (days 4–6, during defervescence)

· This is the period of highest risk for plasma leakage. Intravenous fluids may be required; oral intake should be continued if conscious and no abdominal distension.

· Small, frequent sips of clear fluids only. Stop oral intake if vomiting or if patient is in shock.

Phase 3: Early convalescence (after fever subsides, days 7–14)

· Gradually reintroduce soft solids:

· Continue khichdi, soft rice, moong dal soup.

· Steamed and puréed vegetables (carrot, pumpkin, beetroot).

· Fermented rice (pakhala) – traditional Odia dish; easily digested, provides probiotics.

· Soft tofu, tempeh (steamed).

· Well‑cooked mushrooms (shiitake, oyster) – beta‑glucans for immune support.

· Fruit purées without seeds.

· Fluids: Continue coconut water, ORS if needed, clear soups.

Phase 4: Late convalescence (week 3 onwards, full recovery)

· Rebuilding strength and immunity:

· Plant‑forward, whole‑food Mediterranean pattern.

· Emphasise easily digestible plant proteins: moong dal, masoor dal, tofu, tempeh.

· Cooked vegetables; raw salads only when gut fully recovered.

· Fermented foods: kimchi, sauerkraut, kombucha – restore microbiome after illness.

· Omega‑3 rich ALA sources: ground flaxseed, chia seeds, walnuts – introduce slowly.

· Amla, pomegranate, berries – vitamin C and polyphenols.

· Algae oil supplement for EPA/DHA if dietary intake insufficient.

· Foods to minimise or avoid permanently:

· Red and processed meat – not required, pro‑inflammatory, ecologically destructive.

· Industrial seed oils, trans fats, ultra‑processed foods.

· Excess refined sugar and sugary beverages.

---

6. How soon can one expect improvement and the ideal time frame to retest

Clinical improvement:

· Fever typically lasts 2–7 days. Defervescence (sudden drop in temperature) marks the beginning of the critical phase for severe dengue; clinical deterioration can occur at this point despite fever resolution.

· Platelet count nadir occurs around day 5–7, then recovers over 3–7 days. Haematocrit rise precedes plasma leakage.

· Full recovery takes 1–2 weeks; fatigue may persist for weeks to months.

Serological response and retesting:

· NS1 antigen: Best detected days 1–5. Negative NS1 after day 5 does not exclude dengue.

· IgM: Appears day 3–5, peaks at 2 weeks, declines over 2–3 months.

· Single positive IgM with fever = current or very recent infection.

· Do not use IgM to test for cure. IgM may remain positive for months.

· IgG:

· Primary: IgG rises slowly from day 7; paired acute and convalescent (14–21 days) sera showing ≥4‑fold rise confirms primary infection.

· Secondary: IgG is already high in acute sample; convalescent sample may not show further rise.

· PCR: Can be positive up to day 10–12 in some patients; but sensitivity declines after day 5.

Indications for retesting:

· Initial negative with high suspicion: Repeat NS1 + IgM at 48–72 hours if fever persists.

· To confirm acute infection (research/epidemiology): Paired acute (day 1–7) and convalescent (day 14–21) sera for IgG.

· To differentiate primary vs secondary: IgG index or titre in acute phase; useful for prognosis (secondary infection carries higher risk).

· Platelet monitoring: Daily or alternate day full blood count from day 3–4 until platelet count begins to rise and patient is out of critical phase. No role for repeat dengue serology once diagnosis is established.

---

Conclusion

Dengue tests – NS1 antigen, IgM, IgG, and PCR – are tools for diagnosis, not guides to treatment. Positive results confirm the aetiology of a febrile illness and allow early warning of potential deterioration, particularly in secondary infection. There is no specific antiviral; management is meticulous supportive care: paracetamol for fever, avoidance of NSAIDs, judicious fluid therapy, and monitoring for warning signs. Adjunctive use of papaya leaf extract and giloy has traditional acceptance and modest evidence for platelet recovery, but these must never delay or replace medical care. Dietary support during the acute phase emphasises hydration and easily digestible plant‑based foods; convalescence focuses on rebuilding strength with a whole‑food, plant‑forward, ecologically responsible diet. Dengue is a disease of both the individual and the community – vector control remains our primary public health weapon. Interpret the test, treat the patient, and respect the mosquito.

---x---x

Note on dietary recommendations on this site:

For the sake of our environment we adhere to the following dietary preference hierarchy:

1. Plant‑based

2. Fungi / algae / fermented

3. Biotechnology / lab‑grown / cultures

4. Dairy / eggs

5. Meat / fish / poultry (only if no effective alternative exists)

This approach reflects ecological responsibility, antibiotic stewardship, and the urgent need to reduce the environmental footprint of dietary recommendations. During acute dengue, digestibility and safety take precedence; the hierarchy is applied during convalescence and in long‑term dietary patterns.

-x-x